NHIA Member Home
Find a Provider

News Category: Commercial Payors

NHIA Releases 2024 Commercial Payor Recommendations

  • March 11, 2024
The National Home Infusion Association (NHIA) has developed recommendations for commercial, Medicaid, and Medicare Advantage payors to improve patient outcomes and experience, reduce administrative burden, and improve timely access to home infusion services.

NHIA to Hold Second Home and Specialty Infusion Payor Summit

  • May 23, 2023
The National Home Infusion Association (NHIA) is pleased to hold its second annual one-day Payor Summit. The event, designed to bring together representatives from commercial health insurance plans with home and specialty infusion leaders, will take place August 23, 2023 in Dallas, TX.

NHIA Secures New Home Infusion Service HCPCS Code for Injectable Immunotherapies

  • March 21, 2023
The National Home Infusion Association (NHIA) is pleased to announce that it successfully petitioned the Centers for Medicare and Medicaid Services (CMS) to secure a new billing code for injectable immunotherapies and revise an existing code to facilitate administration of a wider range of monoclonal antibodies for Respiratory Syncytial Virus (RSV).

Home Infusion Nurse Time for Intravenous Immune Globulin: Findings From a Multi-Center Observational Time Study

August 3, 2026

Full text | Download pdf

https://doi.org/10.70776/ECBT6827

Danell Haines, PhD — Research Consultant | Michelle C. Simpson, PharmD, BCSCP, MWC — National Home Infusion Association | Jennifer Charron, RN, MSN, MBA — National Home Infusion Association

Home administered intravenous immune globulin (IVIG) is well established as a patient-centered alternative to facility-based infusion. Safe delivery of home based IVIG relies on appropriate infusion support, which may include an infusion nurse to prepare and administer therapy, monitor the patient’s response, perform vascular access care, provide patient education, coordinate care, and communicate with the interdisciplinary team.

Read More »

Onboarding Home Infusion Anti-Infective Patients: A Descriptive Study of Nurse and Pharmacist Time

August 3, 2026

Full text | Download pdf

https://doi.org/10.70776/KXON8746

Danell Haines, PhD — Research Consultant | Michelle C. Simpson, PharmD, BCSCP, MWC — National Home Infusion Association | Jennifer Charron, RN, MSN, MBA — National Home Infusion Association

Home infusion anti-infective therapy is an important component of post-acute care, allowing patients to transition more quickly from facility-based treatment to home-based intravenous therapy. The patient onboarding phase is a critical and resource-intensive period that requires coordinated activities by nurses and pharmacists, including clinical assessment, care planning, medication preparation, patient education, documentation, and communication with prescribers and other care team members. Home infusion providers invest professional time toward patient onboarding before payment begins, and a significant proportion of referred patients may not ultimately receive billable home infusion services. Limited evidence exists quantifying the combined nursing and pharmacist time required to onboard home infusion anti-infective patients. This study evaluated the time and task distribution associated with nurse and pharmacist tasks during patient onboarding activities for home infusion anti-infective therapy.

Read More »

A Multi-Center Time Study of Home Infusion Nurse Services During Therapy Initiation

August 3, 2026

Full text | Download pdf

https://doi.org/10.70776/BVXP9818

Danell Haines, PhD — Research Consultant | Michelle C. Simpson, PharmD, BCSCP, MWC — National Home Infusion Association | Jennifer Charron, RN, MSN, MBA — National Home Infusion Association

Home infusion therapy is an established and growing model of care that allows patients to receive complex infusion treatments in the home setting. Successful initiation of home infusion therapy requires coordinated nurse, pharmacy, and prescriber involvement, particularly during the transition from referral to the first home visits. Although home infusion nurses perform a wide range of clinical and coordination activities, limited published data describe the time required to deliver these services or how nurse workload varies by therapy type. This multicenter descriptive observational time study quantified home infusion nurse time and task distribution during therapy initiation for anti-infective and intravenous monoclonal antibody therapies.

Read More »

NHIA Announces Innovation Award Finalists

April 14, 2026

The National Home Infusion Association has announced the finalists for its 2026 Exhibitor Innovation Award. The award recognizes groundbreaking products or services that advance the home and alternate site infusion industry.

Read More »

Evaluation of Overridden Drug Utilization Review (DUR) Alerts in an Ambulatory Pharmacy Dispensing System: Patterns, Documentation Practices, and Opportunities for Optimization

April 2, 2026

Full text | Download pdf

https://doi.org/10.70776/TJLU1217

Jennifer Zhao PharmD, Johns Hopkins Care at Home | Tricia Schneider PharmD, MBA, Johns Hopkins Care at Home | Krista Decker RPh, MSQA, Johns Hopkins Care at Home

Drug utilization review (DUR) systems are important for ensuring medication safety by identifying medication-related issues, such as Drug-Drug interactions and therapy duplications. While DUR
alerts support clinical decision-making, excessive or clinically irrelevant alerts can lead to alert fatigue. This can potentially cause pharmacists to overlook crucial warnings and jeopardize patient safety.

Read More »

Social Determinants of Health Impact on Patient Perception within a Home Infusion and Specialty Pharmacy Setting

March 31, 2026

Full text | Download pdf

https://doi.org/10.70776/KVJG2814

Leslie Myers PharmD, IgCP, CSI Pharmacy | Elizabeth Neal RN, IgCN, CSI Pharmacy | Edward O’Bryan MD, MBA, CPE, CSI Pharmacy | Michele Way PharmD, IgCP, BCSCP, CSI Pharmacy | Taylor Cathcart RN, CSI Pharmacy | Elizabeth Duruz R.Ph., CSP, IgCP, CSI Pharmacy | James Sheets PharmD, IgCP, CSI Pharmacy | Timothy P. Walton MHS, CCRP, CSI Pharmacy

Home infusion therapy is an established alternative site of care, from a hospital or outpatient infusion center, for patients requiring administration of infusion medications through a needle or venous access device.

Read More »

Home Infusion Nurse Time for Intravenous Immune Globulin: Findings From a Multi-Center Observational Time Study

August 3, 2026

Full text | Download pdf

https://doi.org/10.70776/ECBT6827

Danell Haines, PhD — Research Consultant | Michelle C. Simpson, PharmD, BCSCP, MWC — National Home Infusion Association | Jennifer Charron, RN, MSN, MBA — National Home Infusion Association

Home administered intravenous immune globulin (IVIG) is well established as a patient-centered alternative to facility-based infusion. Safe delivery of home based IVIG relies on appropriate infusion support, which may include an infusion nurse to prepare and administer therapy, monitor the patient’s response, perform vascular access care, provide patient education, coordinate care, and communicate with the interdisciplinary team.

Read More »

Onboarding Home Infusion Anti-Infective Patients: A Descriptive Study of Nurse and Pharmacist Time

August 3, 2026

Full text | Download pdf

https://doi.org/10.70776/KXON8746

Danell Haines, PhD — Research Consultant | Michelle C. Simpson, PharmD, BCSCP, MWC — National Home Infusion Association | Jennifer Charron, RN, MSN, MBA — National Home Infusion Association

Home infusion anti-infective therapy is an important component of post-acute care, allowing patients to transition more quickly from facility-based treatment to home-based intravenous therapy. The patient onboarding phase is a critical and resource-intensive period that requires coordinated activities by nurses and pharmacists, including clinical assessment, care planning, medication preparation, patient education, documentation, and communication with prescribers and other care team members. Home infusion providers invest professional time toward patient onboarding before payment begins, and a significant proportion of referred patients may not ultimately receive billable home infusion services. Limited evidence exists quantifying the combined nursing and pharmacist time required to onboard home infusion anti-infective patients. This study evaluated the time and task distribution associated with nurse and pharmacist tasks during patient onboarding activities for home infusion anti-infective therapy.

Read More »

A Multi-Center Time Study of Home Infusion Nurse Services During Therapy Initiation

August 3, 2026

Full text | Download pdf

https://doi.org/10.70776/BVXP9818

Danell Haines, PhD — Research Consultant | Michelle C. Simpson, PharmD, BCSCP, MWC — National Home Infusion Association | Jennifer Charron, RN, MSN, MBA — National Home Infusion Association

Home infusion therapy is an established and growing model of care that allows patients to receive complex infusion treatments in the home setting. Successful initiation of home infusion therapy requires coordinated nurse, pharmacy, and prescriber involvement, particularly during the transition from referral to the first home visits. Although home infusion nurses perform a wide range of clinical and coordination activities, limited published data describe the time required to deliver these services or how nurse workload varies by therapy type. This multicenter descriptive observational time study quantified home infusion nurse time and task distribution during therapy initiation for anti-infective and intravenous monoclonal antibody therapies.

Read More »

NHIA Announces Innovation Award Finalists

April 14, 2026

The National Home Infusion Association has announced the finalists for its 2026 Exhibitor Innovation Award. The award recognizes groundbreaking products or services that advance the home and alternate site infusion industry.

Read More »

Evaluation of Overridden Drug Utilization Review (DUR) Alerts in an Ambulatory Pharmacy Dispensing System: Patterns, Documentation Practices, and Opportunities for Optimization

April 2, 2026

Full text | Download pdf

https://doi.org/10.70776/TJLU1217

Jennifer Zhao PharmD, Johns Hopkins Care at Home | Tricia Schneider PharmD, MBA, Johns Hopkins Care at Home | Krista Decker RPh, MSQA, Johns Hopkins Care at Home

Drug utilization review (DUR) systems are important for ensuring medication safety by identifying medication-related issues, such as Drug-Drug interactions and therapy duplications. While DUR
alerts support clinical decision-making, excessive or clinically irrelevant alerts can lead to alert fatigue. This can potentially cause pharmacists to overlook crucial warnings and jeopardize patient safety.

Read More »

Social Determinants of Health Impact on Patient Perception within a Home Infusion and Specialty Pharmacy Setting

March 31, 2026

Full text | Download pdf

https://doi.org/10.70776/KVJG2814

Leslie Myers PharmD, IgCP, CSI Pharmacy | Elizabeth Neal RN, IgCN, CSI Pharmacy | Edward O’Bryan MD, MBA, CPE, CSI Pharmacy | Michele Way PharmD, IgCP, BCSCP, CSI Pharmacy | Taylor Cathcart RN, CSI Pharmacy | Elizabeth Duruz R.Ph., CSP, IgCP, CSI Pharmacy | James Sheets PharmD, IgCP, CSI Pharmacy | Timothy P. Walton MHS, CCRP, CSI Pharmacy

Home infusion therapy is an established alternative site of care, from a hospital or outpatient infusion center, for patients requiring administration of infusion medications through a needle or venous access device.

Read More »
News Archive